Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older
Clinical trial NCT05624606 · COMPLETED
Trial details
- NCT number
- NCT05624606
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2024-03-28
- Enrollment
- 682
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.